Lilly to seek Jaypirca label expansion for first-line CLL/SLL usage
Lilly’s BTK will continue to compete with AbbVie and J&J’s Imbruvica and BeOne Medicines’s Brukinsa.
09 September 2025
09 September 2025
Lilly’s BTK will continue to compete with AbbVie and J&J’s Imbruvica and BeOne Medicines’s Brukinsa.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.